<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6061808</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/bty163</article-id>
    <article-id pub-id-type="publisher-id">bty163</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>EWAS: epigenome-wide association study software 2.0</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Xu</surname>
          <given-names>Jing</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="author-notes" rid="bty163-FM2"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Linna</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="author-notes" rid="bty163-FM2"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Di</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="author-notes" rid="bty163-FM2"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hu</surname>
          <given-names>Simeng</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="author-notes" rid="bty163-FM2"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Song</surname>
          <given-names>Xiuling</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Jin</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lv</surname>
          <given-names>Hongchao</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Duan</surname>
          <given-names>Lian</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Mingming</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jiang</surname>
          <given-names>Qinghua</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Guiyou</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jin</surname>
          <given-names>Shuilin</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff4">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liao</surname>
          <given-names>Mingzhi</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Meng</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="aff" rid="bty163-aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Feng</surname>
          <given-names>Rennan</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="aff" rid="bty163-aff6">6</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kong</surname>
          <given-names>Fanwu</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff7">7</xref>
        <xref ref-type="corresp" rid="bty163-cor1"/>
        <!--<email>kidney1979@163.com</email>-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Xu</surname>
          <given-names>Liangde</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="corresp" rid="bty163-cor1"/>
        <!--<email>xuliangde@hrbmu.edu.cn</email>-->
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jiang</surname>
          <given-names>Yongshuai</given-names>
        </name>
        <xref ref-type="aff" rid="bty163-aff1">1</xref>
        <xref ref-type="aff" rid="bty163-aff2">2</xref>
        <xref ref-type="corresp" rid="bty163-cor1"/>
        <!--<email>jiangyongshuai@gmail.com</email>-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Valencia</surname>
          <given-names>Alfonso</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <aff id="bty163-aff1"><label>1</label>College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China</aff>
    <aff id="bty163-aff2"><label>2</label>Training Center for Students Innovation and Entrepreneurship Education, Harbin Medical University, Harbin, China</aff>
    <aff id="bty163-aff3"><label>3</label>Center for Bioinformatics, School of Life Science and Technology, Harbin Institute of Technology, Harbin, China</aff>
    <aff id="bty163-aff4"><label>4</label>Department of Mathematics, Harbin Institute of Technology, Harbin, China</aff>
    <aff id="bty163-aff5"><label>5</label>College of Life Science, Northwest A&amp;F University, Yangling, Shaanxi, China</aff>
    <aff id="bty163-aff6"><label>6</label>Department of Nutrition and Food Hygiene, Public Health College, Harbin Medical University, Harbin, China</aff>
    <aff id="bty163-aff7"><label>7</label>Department of Nephrology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China</aff>
    <author-notes>
      <fn id="bty163-FM2">
        <p>The authors wish it to be known that, in their opinion, Jing Xu, Linna Zhao, Di Liu and Simeng Hu authors should be regarded as Joint First Authors.</p>
      </fn>
      <corresp id="bty163-cor1">To whom correspondence should be addressed. Email: <email>jiangyongshuai@gmail.com</email> or <email>xuliangde@hrbmu.edu.cn</email> or <email>kidney1979@163.com</email></corresp>
    </author-notes>
    <pub-date pub-type="ppub">
      <day>01</day>
      <month>8</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2018-03-16">
      <day>16</day>
      <month>3</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>16</day>
      <month>3</month>
      <year>2018</year>
    </pub-date>
    <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
    <volume>34</volume>
    <issue>15</issue>
    <fpage>2657</fpage>
    <lpage>2658</lpage>
    <history>
      <date date-type="received">
        <day>05</day>
        <month>10</month>
        <year>2017</year>
      </date>
      <date date-type="rev-recd">
        <day>27</day>
        <month>2</month>
        <year>2018</year>
      </date>
      <date date-type="accepted">
        <day>15</day>
        <month>3</month>
        <year>2018</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>Â© The Author(s) 2018. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2018</copyright-year>
      <license license-type="cc-by-nc" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="bty163.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>With the development of biotechnology, DNA methylation data showed exponential growth. Epigenome-wide association study (EWAS) provide a systematic approach to uncovering epigenetic variants underlying common diseases/phenotypes. But the EWAS software has lagged behind compared with genome-wide association study (GWAS). To meet the requirements of users, we developed a convenient and useful software, EWAS2.0.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>EWAS2.0 can analyze EWAS data and identify the association between epigenetic variations and disease/phenotype. On the basis of EWAS1.0, we have added more distinctive features. EWAS2.0 software was developed based on our âpopulation epigenetic frameworkâ and can perform: (i) epigenome-wide single marker association study; (ii) epigenome-wide methylation haplotype (meplotype) association study and (iii) epigenome-wide association meta-analysis. Users can use EWAS2.0 to execute chi-square test, t-test, linear regression analysis, logistic regression analysis, identify the association between epi-alleles, identify the methylation disequilibrium (MD) blocks, calculate the MD coefficient, the frequency of meplotype and Pearson's correlation coefficients and carry out meta-analysis and so on. Finally, we expect EWAS2.0 to become a popular software and be widely used in epigenome-wide associated studies in the future.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>The EWAS software is freely available at <ext-link ext-link-type="uri" xlink:href="http://www.ewas.org.cn">http://www.ewas.org.cn</ext-link> or <ext-link ext-link-type="uri" xlink:href="http://www.bioapp.org/ewas">http://www.bioapp.org/ewas</ext-link>.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">National Natural Science Foundation of China</named-content>
          <named-content content-type="funder-identifier">10.13039/501100001809</named-content>
        </funding-source>
        <award-id>91746113</award-id>
        <award-id>81601422</award-id>
        <award-id>81600403</award-id>
        <award-id>81701350</award-id>
        <award-id>31501062</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <named-content content-type="funder-name">Basic Research Program of Shenzhen</named-content>
        </funding-source>
        <award-id>JCYJ20160229203627477</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="2"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Epigenome-wide association study (EWAS) is an effective tool to identify the association between epigenetic variation and common disease/phenotype (<xref rid="bty163-B4" ref-type="bibr">Rakyan <italic>et al.</italic>, 2011</xref>; <xref rid="bty163-B5" ref-type="bibr">Wahl <italic>et al.</italic>, 2017</xref>). Compared with genome-wide association study (GWAS), the analysis tools of EWAS have lagged behind. To fill this gap, we developed novel and unique features, and improved upon the previous version EWAS1.0 (<xref rid="bty163-B6" ref-type="bibr">Xu <italic>et al.</italic>, 2016</xref>).</p>
    <p>EWAS1.0 was originally designed only for identifying the association between combinations of methylation levels (beta-value) and diseases. EWAS2.0 (<ext-link ext-link-type="uri" xlink:href="http://www.ewas.org.cn">http://www.ewas.org.cn</ext-link>) is a fully functional software.</p>
  </sec>
  <sec>
    <title>2 Features</title>
    <p>EWAS2.0 software can perform: (i) epigenome-wide single marker association study; (ii) epigenome-wide methylation haplotype (meplotype) association study and (iii) epigenome-wide association meta-analysis. The methylation data should be cleaned and normalized.</p>
    <p>For each DNA methylation loci, EWAS2.0 can carry out t-test or logistic regression analysis to identify the significant associations with case/control or binomial phenotype, perform linear regression analysis to identify the significant results associated with continuous phenotype, and calculate the Pearson's correlation coefficients between beta-value and continuous phenotype.</p>
    <p>According to our âpopulation epigenetic frameworkâ (<xref rid="bty163-B7" ref-type="bibr">Zhao <italic>et al.</italic>, 2016</xref>), EWAS2.0 can analyze the methylation genotypes (menotypes: MM, MU and UU, where M is methylation epi-allele and U is unmethylation epi-allele) data, calculate the epi-allele frequency and identify risk epi-allele (calculate Chi-square, <italic>P</italic>-value, odd ratio and 95% confidential interval). EWAS2.0 can also analyze the association between two epi-alleles (M and U) in the same locus, and label the type of the relationships: synergic (two members of homologous chromosomes tend to be methylated simultaneously) or exclusive (one member of homologous chromosomes is methylated, the other member of homologous chromosomes tends to be unmethylated) (<xref rid="bty163-B7" ref-type="bibr">Zhao <italic>et al.</italic>, 2016</xref>).</p>
    <p>For multiple DNA methylation loci that are physically close to each other, there are non-random associations of epi-alleles between these loci, which we call methylation disequilibrium (MD) (<xref rid="bty163-B7" ref-type="bibr">Zhao <italic>et al.</italic>, 2016</xref>). EWAS2.0 can calculate the MD coefficients (<xref rid="bty163-B7" ref-type="bibr">Zhao <italic>et al.</italic>, 2016</xref>), identify the MD blocks using Gabriel <italic>et al</italic>.âs algorithm (<xref rid="bty163-B1" ref-type="bibr">Barrett <italic>et al.</italic>, 2005</xref>; <xref rid="bty163-B3" ref-type="bibr">Gabriel <italic>et al.</italic>, 2002</xref>) and estimate the frequency of meplotype (a group of specific epi-alleles on a chromosome) using Excoffier <italic>et al</italic>.âs Maximum Likelihood Estimate method (<xref rid="bty163-B2" ref-type="bibr">Excoffier and Slatkin, 1995</xref>). For case/control data, EWAS2.0 can scan the whole epigenome and identify the disease-related meplotype (calculate Chi-square, <italic>P</italic>-value, odd ratio and 95% confidential interval). We suggest that users perform meplotype analysis to identify the combinations of some SMP loci related to diseases/phenotypes after performing the single SMP analysis.</p>
    <p>Since the results of the similar EWAS studies are often inconsistent, we developed an epigenome-wide meta-analysis module. At first, EWAS2.0 test the heterogeneity between individual studies using Cochranâs Q-statistics. Then, the fixed effects model (all studies share a common effect size) and a random effects model (each study has a specific effect size) were used to evaluate the association between marker and disease/phenotype. We suggest that users select fixed effects model for low heterogeneity, and random effects model for high heterogeneity.</p>
    <p>EWAS2.0 software is a JAVA application based on JAVA 1.7 and is freely available at: <ext-link ext-link-type="uri" xlink:href="http://www.ewas.org.cn">http://www.ewas.org.cn</ext-link>. The current status of EWAS2.0 is depicted in <xref rid="bty163-T1" ref-type="table">TableÂ 1</xref>. More functions will be added in the future version (such as EWAS for gene region, KEGG pathway, GO categories, network, interacting with genetic marker, regulation of gene expression, RNA modification, histone modification). Some comparisons between different methods can be found in a supplement (<ext-link ext-link-type="uri" xlink:href="http://www.bioapp.org/ewas/supplement.html">http://www.bioapp.org/ewas/supplement.html</ext-link>). We expect it to become a useful tool.
<table-wrap id="bty163-T1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Overview of novel functions in EWAS2.0</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col valign="top" align="left" span="1"/><col valign="top" align="left" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Category</th><th align="left" rowspan="1" colspan="1">Description</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">-t.test</td><td rowspan="1" colspan="1">T-test for case/control or binomial phenotype</td></tr><tr><td rowspan="1" colspan="1">-linear</td><td rowspan="1" colspan="1">Linear regression analysis for continuous phenotype</td></tr><tr><td rowspan="1" colspan="1">-logistic</td><td rowspan="1" colspan="1">Logistic regression analysis for case/control or binomial phenotype</td></tr><tr><td rowspan="1" colspan="1">-cor</td><td rowspan="1" colspan="1">The Pearson's correlation coefficients for continuous phenotype</td></tr><tr><td rowspan="1" colspan="1">-SMP.allele_chisq</td><td rowspan="1" colspan="1">Chisq-square test for epi-allele: 2 (phenotype)*2 (M vs. U) table</td></tr><tr><td rowspan="1" colspan="1">-SMP.aa</td><td rowspan="1" colspan="1">Identify the type of epi-allele association: synergic or exclusive</td></tr><tr><td rowspan="1" colspan="1">-meplotype</td><td rowspan="1" colspan="1">Epigenome-wide meplotype association analysis</td></tr><tr><td rowspan="1" colspan="1">-MD</td><td rowspan="1" colspan="1">Calculate the MD coefficient</td></tr><tr><td rowspan="1" colspan="1">-block</td><td rowspan="1" colspan="1">Identify the MD blocks and calculate the frequency of meplotype</td></tr><tr><td rowspan="1" colspan="1">-meta</td><td rowspan="1" colspan="1">Epigenome-wide association meta-analysis</td></tr></tbody></table></table-wrap></p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgements</title>
    <p>We are grateful to users from more than 30 countries whose feedback helped improve the functionality and usability of EWAS2.0.</p>
    <sec>
      <title>Funding</title>
      <p>This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 91746113, 81601422, 81600403, 81701350, 31501062) and the Basic Research Program of Shenzhen (JCYJ20160229203627477). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      <p><italic>Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="bty163-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barrett</surname><given-names>J.C.</given-names></name></person-group><etal>et al</etal> (<year>2005</year>) 
<article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title>. <source>Bioinformatics</source>, <volume>21</volume>, <fpage>263</fpage>â<lpage>265</lpage>.<pub-id pub-id-type="pmid">15297300</pub-id></mixed-citation>
    </ref>
    <ref id="bty163-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Excoffier</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Slatkin</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>) 
<article-title>Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population</article-title>. <source>Mol. Biol. Evol</source>., <volume>12</volume>, <fpage>921</fpage>â<lpage>927</lpage>.<pub-id pub-id-type="pmid">7476138</pub-id></mixed-citation>
    </ref>
    <ref id="bty163-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabriel</surname><given-names>S.B.</given-names></name></person-group><etal>et al</etal> (<year>2002</year>) 
<article-title>The structure of haplotype blocks in the human genome</article-title>. <source>Science</source>, <volume>296</volume>, <fpage>2225</fpage>â<lpage>2229</lpage>.<pub-id pub-id-type="pmid">12029063</pub-id></mixed-citation>
    </ref>
    <ref id="bty163-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rakyan</surname><given-names>V.K.</given-names></name></person-group><etal>et al</etal> (<year>2011</year>) 
<article-title>Epigenome-wide association studies for common human diseases</article-title>. <source>Nat. Rev. Genet</source>., <volume>12</volume>, <fpage>529</fpage>â<lpage>541</lpage>.<pub-id pub-id-type="pmid">21747404</pub-id></mixed-citation>
    </ref>
    <ref id="bty163-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wahl</surname><given-names>S.</given-names></name></person-group><etal>et al</etal> (<year>2017</year>) 
<article-title>Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity</article-title>. <source>Nature</source>, <volume>541</volume>, <fpage>81</fpage>â<lpage>86</lpage>.<pub-id pub-id-type="pmid">28002404</pub-id></mixed-citation>
    </ref>
    <ref id="bty163-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>J.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>EWAS: epigenome-wide association studies software 1.0 - identifying the association between combinations of methylation levels and diseases</article-title>. <source>Sci. Rep</source>., <volume>6</volume>, <fpage>37951.</fpage><pub-id pub-id-type="pmid">27892496</pub-id></mixed-citation>
    </ref>
    <ref id="bty163-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>L.</given-names></name></person-group><etal>et al</etal> (<year>2016</year>) 
<article-title>The framework for population epigenetic study</article-title>. <source>Brief. Bioinf</source>., <volume>19</volume>, <fpage>89</fpage>â<lpage>100</lpage>.</mixed-citation>
    </ref>
  </ref-list>
</back>
